Presentation of the occurring results of a survey conducted this year by PTSR among people with MS on the diagnosis and treatment of multiple sclerosis in Poland. Treatment of multiple sclerosis as an investment in patient health and social benefit in Poland. Improving access to treatment in drug program B.29 "Treatment of multiple sclerosis". Unification of eligibility criteria for botulinum toxin type A treatment of patients with spasticity in drug program B.57 - experts' position.
Parliamentary Group on Multiple Sclerosis - live
Published July 3, 2024 10:00
fot. Piotr Wójcik
Topics
stwardnienie rosiane